David Mann
Chief Business Officer Singulera Therapeutics Inc
Seminars
Wednesday 24th March 2027
Advancing Treg Therapies in Transplantation Through Clinical Development & Mechanistic Understanding
9:30 am
- Reviewing emerging clinical insights from Treg therapies in transplantation to demonstrate progress toward durable graft tolerance
- Exploring how fundamental Treg biology research is improving understanding of Treg trafficking, persistence, and function in transplant settings
- Determining how mechanistic and clinical findings can inform the next generation of Treg-based therapies and trial designs in transplantation